Federal Judge Rules Trump Administration’s Grant Cancellations Illegal
A federal judge determined on Monday that the Trump administration’s decision to cancel numerous research grants was unlawful, indicating that this action might raise serious concerns regarding racism.
District Judge William Young, from Massachusetts, characterized the administration’s approach as “arbitrary and whimsical.” He noted that abruptly canceling grants focused on topics like gender identity or diversity failed to adhere to long-established government protocols.
During a hearing concerning two lawsuits aimed at recovering the grants, Young pressed government attorneys for a clear definition of diversity, equity, and inclusion (DEI). He questioned how grants intended to examine health disparities—mandated by Congress—could be revoked under such definitions.
Young, appointed by Republican President Ronald Reagan, highlighted what he called the “dark side” of the situation, asserting that there was “explicitly clear” evidence of “racism and discrimination against the American LGBTQ community” in the government’s actions.
“In my forty years on the bench, I’ve never seen such government racism,” he remarked, summarizing the hearing by stating, “There’s no shame.” He mentioned he would issue a written order shortly.
This ruling addresses a fraction of the many National Institutes of Health (NIH) projects that were halted by the administration. The matter is part of two separate lawsuits filed earlier this spring by a coalition of public health organizations, lawyers, and affected scientists. Specific totals regarding the cut grants were not immediately available.
While Young insisted that the funds need to be reinstated, he noted that the recent decision was merely a temporary measure, as it could likely face an appeal.
Andrew Nixon, a spokesperson for the Department of Health and Human Services—NIH’s parent agency—stated that the Trump administration is exploring all legal avenues, including efforts to uphold existing rulings and lawsuits. He claimed that HHS’s choice to abolish funding stemmed from prioritizing ideological agendas over scientifically sound outcomes for the populace.
Although the original lawsuit didn’t directly charge racism, it alleged that the new NIH policy prohibited the study of “certain politically disfavored subjects.” After merging the lawsuit, an attorney noted that NIH provided insufficient acknowledgment of genuine concerns about research undergoing cancellation, reducing communication to “boilerplate letters” sent to universities.
The studies encompassed a range of topics including cardiovascular health, sexually transmitted diseases, depression, Alzheimer’s disease, and alcohol abuse among minors.
One attorney pointed out a significant project aimed at understanding drug behavior across diverse ancestral backgrounds, emphasizing that these funding cuts would have a more profound impact on scientists involved.
In a court filing earlier in the month, a federal attorney argued that the decisions regarding NIH grants for DEI research were justified, claiming the plaintiff’s opposition was based on a misunderstanding of the NIH’s authority to determine grant priorities. Furthermore, Justice Department lawyer Thomas Port Jr. highlighted examples of minority health grants that remained unaffected during the same time period, suggesting that some cuts were warranted based on scientific merit.
The NIH has long been recognized as the largest public supporter of biomedical research globally.
